Tear Biomarkers for Migraine
Starting soon
Conditions studied: Migraine
In brief
The goal of this observational monocentric study is to investigate tear and serum biomarkers in patients with migraine compared with healthy controls, and to explore their potential diagnostic, clinical, and predictive value. In addition to the cross-sectional evaluation, a longitudinal subgroup analysis will be conducted to assess biomarker changes over time during treatment with anti- Calcitonin Gene-Related Peptide (anti-CGRP) therapies.
Key facts
- Study ID
- NCT07690696
- Run by
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- People needed
- 400
- Starts
- 2026-09-30
- Expected to finish
- 2029-09-29
- Last updated by the study team
- 2026-07-10
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.